Robeco Institutional Asset Management B.V. trimmed its holdings in shares of Cencora, Inc. (NYSE:COR – Free Report) by 50.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,458 shares of the company’s stock after selling 46,057 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Cencora were worth $13,649,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Elevation Wealth Partners LLC lifted its holdings in shares of Cencora by 506.2% in the 2nd quarter. Elevation Wealth Partners LLC now owns 97 shares of the company’s stock valued at $27,000 after buying an additional 81 shares during the period. Bell Investment Advisors Inc purchased a new position in Cencora during the second quarter valued at $28,000. Caitlin John LLC acquired a new stake in Cencora in the 2nd quarter worth about $28,000. Cassaday & Co Wealth Management LLC acquired a new stake in shares of Cencora in the first quarter worth approximately $35,000. Finally, Downshift Financial LLC grew its holdings in shares of Cencora by 3,250.0% during the third quarter. Downshift Financial LLC now owns 134 shares of the company’s stock worth $40,000 after buying an additional 130 shares in the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the stock. Evercore restated an “outperform” rating and set a $350.00 price target (up from $330.00) on shares of Cencora in a report on Thursday, August 6th. Wells Fargo & Company lifted their price target on Cencora from $331.00 to $395.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. Weiss Ratings upgraded shares of Cencora from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, October 6th. UBS Group lowered their target price on shares of Cencora from $430.00 to $400.00 and set a “buy” rating on the stock in a research report on Friday, October 16th. Finally, Wall Street Zen raised Cencora from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $366.44.
Get Our Latest Stock Report on Cencora
Cencora Trading Down 2.3%
Shares of COR stock opened at $330.77 on Friday. The company has a current ratio of 0.93, a quick ratio of 0.58 and a debt-to-equity ratio of 3.53. The company has a market capitalization of $63.12 billion, a price-to-earnings ratio of 19.74, a PEG ratio of 1.73 and a beta of 0.58. The firm has a 50-day moving average price of $322.35 and a 200 day moving average price of $304.06. Cencora, Inc. has a twelve month low of $244.82 and a twelve month high of $377.54.
Cencora (NYSE:COR – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, beating analysts’ consensus estimates of $4.35 by $0.13. The company had revenue of $84.75 billion during the quarter, compared to the consensus estimate of $84.31 billion. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.00 EPS. Research analysts forecast that Cencora, Inc. will post 17.87 earnings per share for the current fiscal year.
Cencora Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Friday, August 14th. Cencora’s dividend payout ratio (DPR) is 17.83%.
Insider Buying and Selling at Cencora
In other news, EVP Elizabeth Campbell sold 11,300 shares of Cencora stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $324.12, for a total value of $3,662,556.00. Following the completion of the transaction, the executive vice president owned 19,455 shares in the company, valued at approximately $6,305,754.60. This trade represents a 36.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.38% of the company’s stock.
Cencora Profile
Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical sourcing and distribution company. It provides branded, generic and specialty pharmaceuticals, over-the-counter products and related health care supplies to pharmacies, hospitals, health systems, physician practices and other health care providers.
The company also offers services to pharmaceutical and biotechnology manufacturers, including logistics, commercialization support, market access, consulting, clinical trial support and patient assistance programs.
Featured Stories
- Five stocks we like better than Cencora
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
- Chefs’ Warehouse Has Rallied 76%—Can the Stock Keep Climbing?
- MarketBeat Week in Review – 10/19 – 10/23
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
